Table 1.
The expression of LncRNA in PC
| LncRNA | Cytology | Location | Expression | Function in tumorigenesis | Reference(PMID) |
|---|---|---|---|---|---|
| PCGEM1 | 2q32.2 | PCa Tissues,LNCaP NIH3T3 Nuclear | + | Oncogene | 11050243, 14724589, 27976428 |
| PCAT1 | 8q24.2 | PCa Tissues, DU145 Cytoplasma | + | Oncogene | 24473064 |
| MALAT1 | 11q13.1 | PCa Tissues, Urinary | + | Oncogene/Diagnosis and Prognosis marker | 23845456, 25526020 |
| PVT1 | 8q24.21 | PCa Tissues | + | Oncogene | 27794184 |
| GAS5 | 1q25.1 | PCa Tissues | – | Tumor suppressor | 27743383 |
| CTBP1-AS | 4p16.3 | VCaP Nucleus | + | Oncogene | 23644382 |
| PCA3 | 9q21.22 | Peripheral Blood | + | Diagnosis marker | 27743381 |
| SChLAP1 | 2q31.3 | PCa Tissues | + | Metastasis/Prognosis marker | 25499224 |
| LINC00963 | 9q34.11 | LNCap cells | + | Metastasis | 24691949 |
| SOCS2-AS1 | 12q22 | PCa Tissues | + | Oncogene | 28241429, 27342770 |
| lncRNA FR0348383 | – | PCa Tissues | + | Diagnosis and Prognosis marker | 28272371 |
| lnc-MX1–1 | 21q22.3 | PCa Tissues | + | Prognosis marker | 26797783, 26797523 |
| PCAT-14 | 22q11.23 | 22Rv1 VCaP Nucleus, Plasma | + | Prognosis marker | 27460352, 27566105 |
| lincRNA-p21 | upstream of CDKN1A | Urine Exosomes | – | Tumor suppressor/Prognosis marker | 28272371, 27976420, 25999983 |
| HCG11 | 6q22.2 | PCa Tissues | – | Prognosis marker | 27522256 |
| LncRNA-ATB | 14 | PCa Tissues | + | Treatment target/Prognosis marker | 27176634 |
| UCA1 | 19p13.12 | PCa Tissues | + | Prognosis marker | 27902466 |
| NEAT1 | 11q13.1 | PCa Tissues | + | Prognosis/Predictive marker | 28241429 |
| DRAIC | 15q23 | LNCap Cytoplasma | – | Tumor suppressor | 26200579 |
| Lncrna SNHG1 | – | PCa Tissues | + | Oncogene | 28400279 |
| Lncrna HOXD-AS1 | 2q31.1 | PCa Tissues | + | Oncogene | 28487115 |
| CCAT-2 | 8q24.22 | PCa Tissues | + | Prognosis marker | 27558961 |
| HOTAIR | 12q13.13 | PCa Tissues, CRPC cell Cytoplasma | + | Oncogene/Prognosis marker | 26411689 |
| MEG3 | 14q32.3 | PCa Tissues | – | Tumor suppressor | 26610246, 28241429 |
| H19 | 11p15.5 | M12 Cytoplasma | – | Tumor suppressor | 24988946 |
| PCAT-18 | 18q11.2 | PCa Tissues, Plasma | + | Diagnosis marker/Treatment target | 24519926, 28272371 |
| DANCR | 4q12 | PCa Tissues | + | Metastasis | 27191265 |
| PCAT-29 | 15q23 | LNCap Nucleus | – | Tumor suppressor | 25200579 |
| LINC01296 | 14q11.2 | PC cell Nucleus, Cytoplasma | + | Metastasis/Treatment target/Prognosis marker | 28392705, 28341852 |
| POTEF-AS1 | 2q21.2 | PCa Tissues | + | Oncogene | 28032932 |
| GLIDR | 9p12 | PCa Tissues | + | Oncogene | 28211799 |
| PCAT-5 | 10p11.21 | PCa Tissues | + | Oncogene | 26282172 |
| THBS4–003 | 5p14.1 | PCa Tissues | + | Metastasis | 27357608 |
| lncRNA LOC400891 | – | PCa Tissues | + | Prognosis marker | 26797783 |
Upregulation:+; Downregulaition: -